Innovate with AI/ML and automation
DOWNLOAD WHITE PAPER: Digital Transformation: A New Era for Clinical Trials
As clinical trials are becoming more complex, pharmaceutical companies are turning to digital operating models to improve efficiency and accelerate scientific innovation. In fact, 40-50% of pharma companies benefit from AI,1 with two out of three companies planning to invest more in IT.2
IQVIA is at the forefront of this digital transformation, enhancing study design, optimizing strategies, and providing real-time data insights for sponsors. These advancements are reshaping clinical trials by streamlining processes, enhancing patient experiences, and unlocking valuable insights.
In this white paper, IQVIA’s data science and digital strategy experts explore various technological advancements and their impact on clinical development, decision-making, data integration and overall operational processes.
1 Bain & Company press release. 40% of pharma executives are baking expected savings from Generative AI into 2024 budgets. February 12, 2024.
2 Buntz B. Two-thirds of pharma companies plan to up IT investments in 2024, survey finds. Drug Discovery Trends. December 14, 2023.
Understand how digital transformation is streamlining clinical research and overcoming inefficiencies. Read the white paper.
